Indication intelligence, analysis and sector perception

Regenerative Medicine Earnings Scorecard - Q2/19 - to date

August 5, 2019

A scorecard of earnings of 45 covered  companies The current LPS (loss per share) or net income, cash positions i.e. "runways" - is a reflection of this universe's investing "status"  

RegMed Investors’ (RMi): Worried about Q2 results, think six (6) market factors…

August 5, 2019

Volatility, algorithms, sustainability … but, geopolitical ssues are "trumping" the news Add to the list, trend analysis, momentum’s magnitude, technicals and fundamentals – do they indicate expected pricing performance in 2019? Why spend time finding sector news and analytics … it’s all right here!  News has become "something" sold into

Regenerative Medicine Earnings Scorecard - Q1/19 - to date

May 19, 2019

A scorecard of earnings of 45 covered  companies 41 so far: 2 acquired (AST, OSIR) 1 on acquisition hold - ONCE) and 1 set to be reversed (HSGX) ... The current LPS (loss per share) or net income, cash positions i.e. "runways" - is a reflection of this universe's investing "status"  

Roll Call

The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.